This study aims to implement the IBIS-Survivorship model of care and assess the effectiveness and cost-effectiveness.
IBIS-Survivorship model of care will be rolled out to several hospital and health services (‘study sites’) across Australia over the next 2 and a half years. During the study, the current, usual care (i.e., specialist-led care) will be offered to eligible patients at each study site. Following this, at regular intervals, or “steps”, each study site will be randomly selected to roll out the IBIS-Survivorship model of care for eligible patients. During the study, each patient will only receive the model of care that they are assigned to when they enrol in the study.
IBIS-Survivorhsip Model of Care
The IBIS-Survivorship model of care consists of nurse-coordinated shared follow-up care for people who have completed treatment for early breast cancer.
This Model of Care involves a pre-specified shared-care pathway for post-treatment follow-up, whereby the responsibilities of follow-up care are shared between a patient’s surgeon, medical and radiation oncology team, specialist cancer nurse and the patient’s general practitioner. Moreover, the specialist cancer nurse plays a key role in providing a treatment summary and co-developing a Survivorship Care Plan (SCP) with the patient and the health care team (including the patient’s general practitioner).
Data Collection
Participants will complete a series of questionnaires on a range of patient-reported outcomes at baseline and 6 months and 12 months after completion of their primary treatment for early stage breast cancer. Data will also be collected on safety indicators (i.e. adherence outcomes, unplanned hospitalisations), and process outcomes (i.e. reach, sustainability, implementation (fidelity), and economic evaluation).